GCM Grosvenor Holdings’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.97M Sell
16,983
-6,259
-27% -$2.06M 0.55% 19
2025
Q4
$8.15M Sell
23,242
-652
-3% -$220K 1.16% 17
2025
Q3
$7.72M Sell
23,894
-8,269
-26% -$2.57M 1.17% 17
2025
Q2
$12.5M Sell
32,163
-3,030
-9% -$1.22M 1.79% 11
2025
Q1
$15.3M Sell
35,193
-4,749
-12% -$1.91M 2.37% 6
2024
Q4
$14.7M Sell
39,942
-1,760
-4% -$736K 2.11% 11
2024
Q3
$21.7M Buy
41,702
+10,000
+32% +$5.34M 3.3% 6
2024
Q2
$17.2M Sell
31,702
-13,587
-30% -$7.18M 2.52% 10
2024
Q1
$23.5M Hold
45,289
3.58% 6
2023
Q4
$21.4M Buy
45,289
+15,789
+54% +$7.3M 3.78% 9
2023
Q3
$12.8M Buy
+29,500
New +$13.4M 2.56% 10

Other funds holding ELV

GCM Grosvenor Holdings's ELV Position: Q1 2026 in Review

GCM Grosvenor Holdings reduced its Elevance Health (ELV) stake by 27% in Q1 2026, selling an estimated $2.06M and leaving 16,983 shares worth $4.97M. The position accounts for 0.55% of the portfolio, ranked #19.

GCM Grosvenor Holdings first reported a position in ELV in Q3 2023 and has held it in 11 quarters since. The position peaked at $23.5M in Q1 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • GCM Grosvenor Holdings held 16,983 shares of Elevance Health worth $4.97M as of Q1 2026.
  • GCM Grosvenor Holdings sold 6,259 Elevance Health shares in Q1 2026, an estimated $2.06M.
  • Elevance Health made up 0.55% of GCM Grosvenor Holdings's portfolio in Q1 2026, its #19 holding.
  • GCM Grosvenor Holdings first reported a position in Elevance Health in Q3 2023 and has held it in 11 quarters since.
  • GCM Grosvenor Holdings's Elevance Health position peaked at $23.5M in Q1 2024.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on GCM Grosvenor Holdings's 13F filing for Q1 2026, filed 15 May 2026.